ESWI organised four webinars in June 2020 to address these questions and discuss them amongst peers, clinicians and policymakers.
INFLUENZA AND RSV IN A COVID-19 WORLD
CLINICAL MANIFESTATIONS OF COVID-19, INFLUENZA AND RSV
INTERVENTION STRATEGIES FOR COVID-19, INFLUENZA AND RSV
CORNERSTONES OF PANDEMIC PREPAREDNESS AND URGENT ACTIONS
The following is a summary of the main conclusions and recommendations from each of the four webinars.
The fifth edition of the ESWI Young Scientist Best Body Of Work award goes to Dr. Robert de Vries, Utrecht University, The Netherlands for his substantial accomplishments to date in the field of understanding influenza virus dynamics.
The first edition of the ESWI Young Scientist Innovative Award, a research grant supported by Seqirus, goes to Dr. Kirsty Short, University of Queensland, Australia, for her innovative research in vaccine development.
Both Dr. de Vries and Dr. Short will receive an invitation to give a keynote lecture during the Young Scientists Plenary session at the 7th ESWI Influenza Conference in Valencia, Spain (13-16 September).
Stimulating the careers of promising researchers being one of ESWI’s objectives, several applicants have been invited to co-chair a scientific session at the 2020 Valencia Conference.
100 years ago, an influenza pandemic stunned the world, killing more than 50 million people worldwide. The world remains vulnerable to such outbreaks, and due to the fast evolution of the influenza virus, globalization and intercontinental travel, outbreaks on the scale and severity of the 1918 pandemic would have a devastating effect today. But lessons learned from the past century of research and international cooperation should help prepare the world for future pandemics.
ESWI, in partnership with the Centre on Global Health Security at Chatham House, organized the Influenza Preparedness Stakeholder Conference on the Centenary of the 1918 Pandemic to provide an opportunity to review the advances made over the past 100 years, evaluate current preparedness levels and discuss the pathways required to improve policy engagement.
The conference was held on 22 January 2019. The video-recorded lectures of the meeting are freely available on ESWI TV. Click here to watch the lectures.
The meeting report and a video summary of the stakeholder debate are now available for download.
To support the education of health care professionals on paediatric infectious diseases, the European Society for Paediatric Infectious Diseases offers free access to 5 top sessions from ESPID 2019 until July 31.
This is a great opportunity for anyone who missed these live-streamed sessions or who would just like to watch them again.
The question of flu vaccination for healthcare professionals is an urgent and highly relevant one. After all, the devastating impact of flu is widely recognized, and flu vaccines are estimated to prevent thousands of admissions and millions of illnesses with current usage. At risk groups are well defined. Health care professionals work with the patients at risk on a daily basis. Annual vaccination is widely recommended to reduce the risk of healthcare acquired influenza. Why then is it so difficult to achieve influenza vaccine uptake levels in healthcare workers that would reduce or eliminate the risk of transmitting the disease?
In its 2019 Science Policy Influenza Summit, ESWI will attempt to answer that question in close collaboration
with its partner organizations. Together, we aim to develop a list of actions to stimulate the implementation of vaccination policies for health care professionals.
The meeting will be held in Marseille, France, on 20 November 2019, at the occasion of the 12th European Public Health Conference. For more information, click here.
During the 37th annual meeting of the European Society for Paediatric Infectious Diseases (ESPID), ESWI and ESPID will organize a joint symposium on “Influenza vaccines for children: current issues and developments”.
Confirmed symposium speakers include:
- Ana Mosterin (Cambridge University) on “Influenza B and the rationale for Quadrivalent vaccines”
- Abdullah Brooks (Johns Hopkins) on “Childhood flu vaccination in underprivileged areas: challenges and solutions”
- Ed Belongia (Marshfield Clinic Research Institute) on “Vaccine effectiveness against H3N2 influenza virus in children”.
The symposium will be held during ESPID 2019 on 8 May 2019 in Ljubljana, Slovenia.
Visit the ESPID 2019 website.
On 28 September 2018, ESWI brought together 60 influenza stakeholders for a day of presentations and debates on paediatric influenza vaccination. The aim of the meeting was to bring childhood influenza vaccination to the next level and to that end ESWI organized a stakeholders table for partner organizations, combined with a number of scientific contributions, Q&A and debate. The event was available via live stream video, reaching 590 viewers worldwide, many of whom weighed in on the discussions via Twitter and e-mail.
The report of the lectures and the discussions held at the Summit can now be downloaded here.
ESWI proudly facilitated the formation of a diabetes/influenza community on 8 November 2018 in Leuven. The group’s action plan is currently under preparation and ESWI looks forward to implementing it in close collaboration with our partners:
- The International Diabetes Federation (IDF Europe)
- Foundation of European Nurses in Diabetes (FEND)
- Pharmacist Group to the European Union (PGEU)
- Diabetes UK
- Primary Care Diabetes Europe (PCDE)
- Immunology of Diabetes Society (IDS)
- European Association for the Study of Diabetes (EASD)
- Nurse Practitioner Healthcare Foundation (NPHF)
- American association of diabetes educators (AADE)
- American Pharmacists Association (APhA)